Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Scionti

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Scientific Reports|July 9, 2026
Glucocorticoid exposure during nutrient deprivation impairs recovery in postmitotic myotubesAngelo Galluccio, Alberto Castagna, Samantha Maurotti, et al.
Journal of Translational Medicine|October 23, 2022
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid RhamnetinDaniele Caracciolo, Giada Juli, Caterina Riillo, et al.
International Journal of Molecular Sciences|February 24, 2024
Genetic Biomarkers of Sorafenib Response in Patients with Hepatocellular CarcinomaLydia Giannitrapani, Francesca Di Gaudio, Melchiorre Cervello, et al.
Journal of Hematology & Oncology|March 23, 2019
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myelomaMaria Cucè, Maria Eugenia Gallo Cantafio, Maria Anna Siciliano, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 7, 2019
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severityStefania Di Mauro, Alessandra Scamporrino, Salvatore Petta, et al.
Blood|July 13, 2018
Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-miR-17-92Eugenio Morelli, Lavinia Biamonte, Cinzia Federico, et al.
Molecular Therapy. Nucleic Acids|March 14, 2022
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic reviewMaria Teresa Di Martino, Mariamena Arbitrio, Daniele Caracciolo, et al.
Cancers|June 24, 2022
A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) CellsCaterina Riillo, Daniele Caracciolo, Katia Grillone, et al.
Journal of Hematology & Oncology|June 26, 2023
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation studyPierfrancesco Tassone, Maria Teresa Di Martino, Mariamena Arbitrio, et al.
European Journal of Human Genetics : EJHG|May 13, 2010
High frequency of COH1 intragenic deletions and duplications detected by MLPA in patients with Cohen syndromeVeronica Parri, Eleni Katzaki, Vera Uliana, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Scientific Reports|July 9, 2026
Glucocorticoid exposure during nutrient deprivation impairs recovery in postmitotic myotubesAngelo Galluccio, Alberto Castagna, Samantha Maurotti, et al.
Journal of Translational Medicine|October 23, 2022
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid RhamnetinDaniele Caracciolo, Giada Juli, Caterina Riillo, et al.
International Journal of Molecular Sciences|February 24, 2024
Genetic Biomarkers of Sorafenib Response in Patients with Hepatocellular CarcinomaLydia Giannitrapani, Francesca Di Gaudio, Melchiorre Cervello, et al.
Journal of Hematology & Oncology|March 23, 2019
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myelomaMaria Cucè, Maria Eugenia Gallo Cantafio, Maria Anna Siciliano, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 7, 2019
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severityStefania Di Mauro, Alessandra Scamporrino, Salvatore Petta, et al.
Blood|July 13, 2018
Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-miR-17-92Eugenio Morelli, Lavinia Biamonte, Cinzia Federico, et al.
Molecular Therapy. Nucleic Acids|March 14, 2022
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic reviewMaria Teresa Di Martino, Mariamena Arbitrio, Daniele Caracciolo, et al.
Cancers|June 24, 2022
A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) CellsCaterina Riillo, Daniele Caracciolo, Katia Grillone, et al.
Journal of Hematology & Oncology|June 26, 2023
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation studyPierfrancesco Tassone, Maria Teresa Di Martino, Mariamena Arbitrio, et al.
European Journal of Human Genetics : EJHG|May 13, 2010
High frequency of COH1 intragenic deletions and duplications detected by MLPA in patients with Cohen syndromeVeronica Parri, Eleni Katzaki, Vera Uliana, et al.
Pageof 6